Phase I dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumors.
Takashi Seto
No relevant relationships to disclose
Taito Esaki
No relevant relationships to disclose
Fumihiko Hirai
No relevant relationships to disclose
Shuji Arita
No relevant relationships to disclose
Kaname Nosaki
No relevant relationships to disclose
Akitaka Makiyama
No relevant relationships to disclose
Takuro Kometani
No relevant relationships to disclose
Chinatsu Fujimoto
No relevant relationships to disclose
Motoharu Hamatake
No relevant relationships to disclose
Hiroaki Takeoka
No relevant relationships to disclose
Felix Agbo
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca
Xiaojin Shi
Employment or Leadership Position - AstraZeneca
Stock Ownership - AstraZeneca